GB0623749D0 - Substituted quinazolines - Google Patents

Substituted quinazolines

Info

Publication number
GB0623749D0
GB0623749D0 GBGB0623749.9A GB0623749A GB0623749D0 GB 0623749 D0 GB0623749 D0 GB 0623749D0 GB 0623749 A GB0623749 A GB 0623749A GB 0623749 D0 GB0623749 D0 GB 0623749D0
Authority
GB
United Kingdom
Prior art keywords
substituted quinazolines
quinazolines
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623749.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire LLC
Original Assignee
Shire LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire LLC filed Critical Shire LLC
Priority to GBGB0623749.9A priority Critical patent/GB0623749D0/en
Publication of GB0623749D0 publication Critical patent/GB0623749D0/en
Priority to BRPI0719568-0A priority patent/BRPI0719568A2/pt
Priority to CA002670168A priority patent/CA2670168A1/en
Priority to AU2007327048A priority patent/AU2007327048B2/en
Priority to MX2009005578A priority patent/MX2009005578A/es
Priority to EA200900742A priority patent/EA017139B1/ru
Priority to MYPI20092152A priority patent/MY149620A/en
Priority to PCT/GB2007/050698 priority patent/WO2008065445A1/en
Priority to CN2007800442221A priority patent/CN101558048B/zh
Priority to KR1020097011681A priority patent/KR20090089865A/ko
Priority to JP2009538793A priority patent/JP2010511031A/ja
Priority to EP07824910A priority patent/EP2097390A1/en
Priority to TW096145029A priority patent/TW200829252A/zh
Priority to ARP070105273A priority patent/AR064003A1/es
Priority to IL198808A priority patent/IL198808A0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0623749.9A 2006-11-28 2006-11-28 Substituted quinazolines Ceased GB0623749D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0623749.9A GB0623749D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines
EP07824910A EP2097390A1 (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives wuth blood platelet reducing properties
MYPI20092152A MY149620A (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives with blood platelet reducing properties
CN2007800442221A CN101558048B (zh) 2006-11-28 2007-11-19 具有血小板降低性质的氨基喹唑啉衍生物
AU2007327048A AU2007327048B2 (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives with blood platelet reducing properties
MX2009005578A MX2009005578A (es) 2006-11-28 2007-11-19 Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre.
EA200900742A EA017139B1 (ru) 2006-11-28 2007-11-19 Производные аминохиназолина с понижающими тромбоциты свойствами
BRPI0719568-0A BRPI0719568A2 (pt) 2006-11-28 2007-11-19 Derivados de amino quinazolinas com propriedades de redução de plaquetas sanguíneas
PCT/GB2007/050698 WO2008065445A1 (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives wuth blood platelet reducing properties
CA002670168A CA2670168A1 (en) 2006-11-28 2007-11-19 Amino quinazolines derivatives wuth blood platelet reducing properties
KR1020097011681A KR20090089865A (ko) 2006-11-28 2007-11-19 혈소판 감소 성질을 갖는 아미노 퀴나졸린 유도체
JP2009538793A JP2010511031A (ja) 2006-11-28 2007-11-19 血小板減少性を有するアミノキナゾリン誘導体
TW096145029A TW200829252A (en) 2006-11-28 2007-11-27 Substituted quinazolines
ARP070105273A AR064003A1 (es) 2006-11-28 2007-11-28 Quinazolinas sustituidas
IL198808A IL198808A0 (en) 2006-11-28 2009-05-19 Amino quinazolines derivatives with blood platelet reducing properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623749.9A GB0623749D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines

Publications (1)

Publication Number Publication Date
GB0623749D0 true GB0623749D0 (en) 2007-01-10

Family

ID=37671459

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623749.9A Ceased GB0623749D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines

Country Status (15)

Country Link
EP (1) EP2097390A1 (es)
JP (1) JP2010511031A (es)
KR (1) KR20090089865A (es)
CN (1) CN101558048B (es)
AR (1) AR064003A1 (es)
AU (1) AU2007327048B2 (es)
BR (1) BRPI0719568A2 (es)
CA (1) CA2670168A1 (es)
EA (1) EA017139B1 (es)
GB (1) GB0623749D0 (es)
IL (1) IL198808A0 (es)
MX (1) MX2009005578A (es)
MY (1) MY149620A (es)
TW (1) TW200829252A (es)
WO (1) WO2008065445A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822970D0 (en) * 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
CN103254197A (zh) * 2013-05-29 2013-08-21 黑龙江大学 一种盐酸阿那格雷的制备方法
PL3236967T3 (pl) 2014-12-22 2020-04-30 Suda Pharmaceuticals Ltd Zapobieganie i leczenie przerzutów u pacjentów z nadpłytkowością typu nowotworowego

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146718A (en) * 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
US6194420B1 (en) * 1999-11-30 2001-02-27 Roberts Laboratories Inc. 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
DE10301105B4 (de) * 2003-01-09 2005-11-24 Chemisch-Pharmazeutisches Labor, Rolf Sachse Gmbh Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation
EA010871B1 (ru) * 2003-01-23 2008-12-30 Шир Холдингз Аг Трансдермальные составы и способы лечения тромбоцитемии
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia

Also Published As

Publication number Publication date
BRPI0719568A2 (pt) 2013-12-10
MX2009005578A (es) 2009-07-29
MY149620A (en) 2013-09-13
JP2010511031A (ja) 2010-04-08
EP2097390A1 (en) 2009-09-09
TW200829252A (en) 2008-07-16
AU2007327048B2 (en) 2012-01-12
CN101558048B (zh) 2012-07-25
WO2008065445A1 (en) 2008-06-05
AU2007327048A1 (en) 2008-06-05
EA017139B1 (ru) 2012-10-30
IL198808A0 (en) 2010-02-17
EA200900742A1 (ru) 2010-08-30
AR064003A1 (es) 2009-03-04
KR20090089865A (ko) 2009-08-24
CA2670168A1 (en) 2008-06-05
CN101558048A (zh) 2009-10-14

Similar Documents

Publication Publication Date Title
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) ELECTRONIC COUPONS
EP2033216A4 (en) ELEKTROADHÄSION
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
PL1849352T3 (pl) Kombajn
DE602007003855D1 (en) Isothermer reaktor
EP1983992A4 (en) 2-IMINO-BENZIMIDAZOLES
DE602007001601D1 (en) Glasuntersuchung
IL192799A0 (en) Substituted 4-phenylpiperidines
DE602007006989D1 (en) Spiropiperidinderivate
ZA201008177B (en) Substituted quinazolines
HK1132994A1 (en) Mtki quinazoline derivatives mtki
IL198809A0 (en) Substituted quinazolines
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2050739A4 (en) quinazoline derivative
EP2084019A4 (en) PAINT SCRAPER
GB0808947D0 (en) Substituted quinazolines
GB0808944D0 (en) Substituted quinazolines
EP2024567A4 (en) TONTAPETE
GB0623749D0 (en) Substituted quinazolines
ZA200903382B (en) Substituted 4-imidazoles
GB0808951D0 (en) Substituted quinazolines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)